UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 714

Sortiert nach

COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.2891-2904

2020

Link zum Volltext

Verfügbarkeit prüfen

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.2921-2931

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.3055-3060

2020

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 reinfection and implications for vaccine development

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.3061-3073

2020

Link zum Volltext

Verfügbarkeit prüfen

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.2913-2920

2020

Link zum Volltext

Verfügbarkeit prüfen

The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization

Human vaccines & immunotherapeutics, 2021-03, Vol.17 (3), p.638-643

2021

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in vaccine and immunotherapy for COVID-19

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.3011-3022

2020

Link zum Volltext

Verfügbarkeit prüfen

Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2357424-2357424

2024

Link zum Volltext

Verfügbarkeit prüfen

Exploring the possible use of saponin adjuvants in COVID-19 vaccine

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.2944-2953

2020

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 vaccine candidates in rapid development

Human vaccines & immunotherapeutics, 2021-03, Vol.17 (3), p.644-653

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies

Human vaccines & immunotherapeutics, 2021-04, Vol.17 (4), p.1122-1127

Rele, Shyam

2021

Link zum Volltext

Verfügbarkeit prüfen

Decoding trends in mRNA vaccine research: A comprehensive bibliometric study

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2355037

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2342592-2342592

2024

Link zum Volltext

Verfügbarkeit prüfen

Exosome may be the next generation of promising cell-free vaccines

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2345940

2024

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.3034-3042

2020

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations

Human vaccines & immunotherapeutics, 2021-04, Vol.17 (4), p.1097-1108

2021

Link zum Volltext

Verfügbarkeit prüfen

Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.2888-2890

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (7), p.2153537-2153537

2022

Link zum Volltext

Verfügbarkeit prüfen

Considerations on the clinical development of COVID-19 vaccine from trial design perspectives

Human vaccines & immunotherapeutics, 2021-03, Vol.17 (3), p.656-660

2021

Link zum Volltext

Verfügbarkeit prüfen

Human vaccines and immunotherapeutics: News April 2024

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2354154

2024

Link zum Volltext

Verfügbarkeit prüfen

Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.2980-2991

2020

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria

Human vaccines & immunotherapeutics, 2021-03, Vol.17 (3), p.661-663

2021

Link zum Volltext

Verfügbarkeit prüfen

An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein

Human vaccines & immunotherapeutics, 2021-01, Vol.17 (1), p.92-97

2021

Link zum Volltext

Verfügbarkeit prüfen

Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2)

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.3001-3010

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 714

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

SpracheDeutsch

ThemaPandemics

Zeitschrift / SerieHuman Vaccines & Immunotherapeutics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(714)
Mit Volltextzugriff
(714)

Publikationsform

Artikel
(714)

Sprache

Englisch
(714)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

Biotechnology & Applied Microbiology
(714)
Immunology
(714)
Life Sciences & Biomedicine
(714)
Science & Technology
(714)
Humans
(563)
Covid-19
(470)
Covid-19 - Prevention & Control
(426)
Sars-Cov-2
(352)
Covid-19 Vaccines
(311)
Vaccination
(311)
Coronavirus
(197)
Vaccine
(144)
Vaccines
(120)
Cross-Sectional Studies
(117)
Adult
(108)
Female
(106)
Vaccine Hesitancy
(97)
Research Paper
(90)
Review
(89)
Covid-19 Vaccines - Adverse Effects
(86)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Taylor & Francis Medical Collection
(714)
Ingenta
(714)
Taylor & Francis
(714)
IngentaConnect Journals
(689)
EZB Electronic Journals Library
(688)
Lippincott E Journal Collection
(682)
MEDLINE
(568)

2 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(38)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19

SARS-CoV-2 reinfection and implications for vaccine development

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects

The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization

Recent advances in vaccine and immunotherapy for COVID-19

Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis

Exploring the possible use of saponin adjuvants in COVID-19 vaccine

SARS-CoV-2 vaccine candidates in rapid development

COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies

Decoding trends in mRNA vaccine research: A comprehensive bibliometric study

Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size

Exosome may be the next generation of promising cell-free vaccines

Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2

COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations

Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges

Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'

Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility

Considerations on the clinical development of COVID-19 vaccine from trial design perspectives

Human vaccines and immunotherapeutics: News April 2024

Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses

COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria

An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein

Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2)

Aktive Filter

Suchergebnisse filtern